UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 3, 2022
Accession Number:
0001104659-22-053539
Submission Type:
POS AM
CIK:
0001719406
Company Name:
NRX Pharmaceuticals, Inc.
File Number:
333-259336